Houston KA, Mitchell KA, King J, White A, Ryan BM. Histologic lung cancer incidence rates and trends vary by race/ethnicity and residential county. J Thorac Oncol. 2018;13:497–509.
Article PubMed PubMed Central Google Scholar
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.
Rami-Porta R, Bolejack V, Giroux DJ, Chansky K, Crowley J, Lyons G, et al. TNM classification for lung cancer. J Thorac Oncol. 2015;10:990–1003.
Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109(1):120–9.
Article CAS PubMed Google Scholar
al-Kattan K, Sepsas E, Fountain SW, Townsend ER. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg. 1997;12(3):380–4.
Article CAS PubMed Google Scholar
Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K, et al. Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients. Thorax. 2010;65:1092–8.
Martini N, Rusch VW, Bains MS, Kris MG, Downey RJ, Flehinger BJ, et al. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer. J Thorac Cardiovasc Surg. 1999;117:32–6.
Article CAS PubMed Google Scholar
Okada M, Nishio W, Sakamoto T, Harada H, Uchino K, Tsubota N, et al. Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma. J Thorac Cardiovasc Surg. 2003;126:558–62.
Maeda R, Yoshida J, Hishida T, Aokage K, Nishimura M, Nishiwaki Y, et al. Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up. Chest. 2010;138:145–50.
Shigefuku S, Shimada Y, Hagiwara M, Kakihana M, Kajiwara N, Ohira T, et al. Prognostic significance of ground-glass opacity components in 5-year survivors with resected lung adenocarcinoma. Ann Surg Oncol. 2021;28:148–56.
Sonoda D, Matsuura Y, Ichinose J, Nakao M, Ninomiya H, Mun M, et al. Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection. Cancer Manag Res. 2019;11:6765–74.
Article PubMed PubMed Central Google Scholar
Sekihara K, Hishida T, Yoshida J, Oki T, Omori T, Katsumata S, et al. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is “cured” from postoperative recurrence? Eur J Cardiothorac Surg. 2017;52(3):522–8.
Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Prognostic impact of a ground-glass opacity component in the clinical T classification of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2017;154(6):2102-2110.e1. https://doi.org/10.1016/j.jtcvs.2017.08.037.
Asamura H, Hishida T, Suzuki K, Koike T, Nakamura K, Kusumoto M, et al. Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg. 2013;146:24–30.
Suzuki K, Koike T, Asakawa T, Kusumoto M, Asamura H, Nagai K, et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 2011;6:751–6.
Ye T, Deng L, Wang S, Xiang J, Zhang Y, Hong Hu, et al. Lung adenocarcinomas manifesting as radiological part-solid nodules define a special clinical subtype. J Thorac Oncol. 2019;14:617–27.
Aokage K, Miyoshi T, Ishii G, Kusumoto M, Nomura S, Katsumata S, et al. Influence of ground-glass opacity and the corresponding pathological findings on survival in patients with clinical stage I non-small cell lung cancer. J Thorac Oncol. 2018;13:533–42.
Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer. 1995;75:2844–52.
Article CAS PubMed Google Scholar
Okiror L, Harling L, Toufektzian L, King J, Routledge T, Karen H-P, et al. Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2018;156:785–93.
Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch WV, Vansteenkiste JF, et al. The International Association for the Study of lung cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10:1675–84.
Article CAS PubMed Google Scholar
Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606–12.
Article CAS PubMed Google Scholar
Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical, and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243–60.
Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.
Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
Article CAS PubMed Google Scholar
Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 year. N Engl J Med. 2017;377(19):1836–46.
Article PubMed PubMed Central Google Scholar
Klotz L, Vesprini D, Sethukavalan P, Jethava V, Zhang L, Jain S, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol. 2015;33(3):272–7.
Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein Thomas JF, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA. 2003;100:7737–42.
Article ADS CAS PubMed PubMed Central Google Scholar
Neophytou CM, Kyriakou TC, Papageorgis P. Mechanisms of metastatic tumor dormancy and implications for cancer therapy. Int J Mol Sci. 2019;20:6158.
Comments (0)